Antitumor Activity of Osimertinib in NSCLC Harboring EGFR Exon 20 Insertions.
Jonathan Riess,Nicolas Floch,Matthew Martin,Jonathon Orme,Anna Staniszewska,Ludovic Menard,Maria Emanuela Cuomo,Daniel O'Neill, Richard Ward,Raymond Finlay,Darren McKerrecher,Mingshan Cheng, Daniel Tang,Rebekah Tsai,Chunting Ye,James G. Keck,David R. Gandara,Philip C. Mack,Darren Cross Journal of clinical oncology（2017）
AI 理解论文
溯源树
样例
